191 related articles for article (PubMed ID: 19909255)
1. The DDAH/ADMA pathway in the control of endothelial cell migration and angiogenesis.
Fiedler LR; Wojciak-Stothard B
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1243-7. PubMed ID: 19909255
[TBL] [Abstract][Full Text] [Related]
2. The ADMA/DDAH pathway regulates VEGF-mediated angiogenesis.
Fiedler LR; Bachetti T; Leiper J; Zachary I; Chen L; Renné T; Wojciak-Stothard B
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2117-24. PubMed ID: 19778944
[TBL] [Abstract][Full Text] [Related]
3. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine.
Feng M; Liu L; Guo Z; Xiong Y
Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305
[TBL] [Abstract][Full Text] [Related]
4. The ADMA/DDAH pathway is a critical regulator of endothelial cell motility.
Wojciak-Stothard B; Torondel B; Tsang LY; Fleming I; Fisslthaler B; Leiper JM; Vallance P
J Cell Sci; 2007 Mar; 120(Pt 6):929-42. PubMed ID: 17327280
[TBL] [Abstract][Full Text] [Related]
5. CT-1 induces angiogenesis by regulating the ADMA/DDAH Pathway.
Zheng ZZ; Tian Fu X; Liang J; Bing Guo Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):540-6. PubMed ID: 25732979
[TBL] [Abstract][Full Text] [Related]
6. The DDAH/ADMA/NOS pathway.
Tran CT; Leiper JM; Vallance P
Atheroscler Suppl; 2003 Dec; 4(4):33-40. PubMed ID: 14664901
[TBL] [Abstract][Full Text] [Related]
7. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.
Richir MC; Bouwman RH; Teerlink T; Siroen MP; de Vries TP; van Leeuwen PA
JPEN J Parenter Enteral Nutr; 2008; 32(6):613-21. PubMed ID: 18974239
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis.
Jacobi J; Sydow K; von Degenfeld G; Zhang Y; Dayoub H; Wang B; Patterson AJ; Kimoto M; Blau HM; Cooke JP
Circulation; 2005 Mar; 111(11):1431-8. PubMed ID: 15781754
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Rac1 activity by ADMA/DDAH regulates pulmonary endothelial barrier function.
Wojciak-Stothard B; Torondel B; Zhao L; Renné T; Leiper JM
Mol Biol Cell; 2009 Jan; 20(1):33-42. PubMed ID: 18923147
[TBL] [Abstract][Full Text] [Related]
10. Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells.
Monsalve E; Oviedo PJ; García-Pérez MA; Tarín JJ; Cano A; Hermenegildo C
Cardiovasc Res; 2007 Jan; 73(1):66-72. PubMed ID: 17097077
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric dimethylarginine, an endogenous NOS inhibitor, is actively metabolized in rat erythrocytes.
Yokoro M; Suzuki M; Murota K; Otsuka C; Yamashita H; Takahashi Y; Tsuji H; Kimoto M
Biosci Biotechnol Biochem; 2012; 76(7):1334-42. PubMed ID: 22785485
[TBL] [Abstract][Full Text] [Related]
12. The biology and therapeutic potential of the DDAH/ADMA pathway.
Arrigoni F; Ahmetaj B; Leiper J
Curr Pharm Des; 2010; 16(37):4089-102. PubMed ID: 21247398
[TBL] [Abstract][Full Text] [Related]
13. Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production.
Pope AJ; Karrupiah K; Kearns PN; Xia Y; Cardounel AJ
J Biol Chem; 2009 Dec; 284(51):35338-47. PubMed ID: 19820234
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA).
Maas R
Vasc Med; 2005 Jul; 10 Suppl 1():S49-57. PubMed ID: 16444869
[TBL] [Abstract][Full Text] [Related]
15. Regulation by DDAH/ADMA pathway of lipopolysaccharide-induced tissue factor expression in endothelial cells.
Xin HY; Jiang DJ; Jia SJ; Song K; Wang GP; Li YJ; Chen FP
Thromb Haemost; 2007 May; 97(5):830-8. PubMed ID: 17479195
[TBL] [Abstract][Full Text] [Related]
16. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.
Millatt LJ; Whitley GS; Li D; Leiper JM; Siragy HM; Carey RM; Johns RA
Circulation; 2003 Sep; 108(12):1493-8. PubMed ID: 12952847
[TBL] [Abstract][Full Text] [Related]
17. [Effect of puerarin on ADMA-DDAH system in human umbilical vein endothelial cells cultured with oxidized free radical].
Li JX; Chen J; Deng ZH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Dec; 26(12):1103-6. PubMed ID: 17205823
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine.
Sharma S; Smith A; Kumar S; Aggarwal S; Rehmani I; Snead C; Harmon C; Fineman J; Fulton D; Catravas JD; Black SM
Vascul Pharmacol; 2010; 52(5-6):182-90. PubMed ID: 19962451
[TBL] [Abstract][Full Text] [Related]
19. Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction.
Jiang DJ; Jia SJ; Yan J; Zhou Z; Yuan Q; Li YJ
Biochem Biophys Res Commun; 2006 Oct; 349(2):683-93. PubMed ID: 16959216
[TBL] [Abstract][Full Text] [Related]
20. The DDAH-ADMA-NOS pathway.
Leiper JM
Ther Drug Monit; 2005 Dec; 27(6):744-6. PubMed ID: 16404814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
